zalcitabine has been researched along with Nerve Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoke, A; Keswani, SC; Rosenberg, B | 1 |
1 other study(ies) available for zalcitabine and Nerve Degeneration
Article | Year |
---|---|
The use of GAP-43 mRNA quantification in high throughput screening of putative neuroprotective agents in dorsal root ganglion cultures.
Topics: Animals; Animals, Newborn; Cell Culture Techniques; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fetus; Ganglia, Spinal; GAP-43 Protein; Gene Expression; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tacrolimus; Zalcitabine | 2004 |